Clinical Trial Update: Vandetanib and Bevacizumab in Treating Patients With Advanced Solid Tumors or Lymphoma [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating vandetanib in combination with bevacizumab in adults with advanced solid tumors or lymphoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer
• Lymphoma
• Lymphoproliferative Disorder
• Small Intestine Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• Vandetanib (vandetanib)

Snippet

Sponsor: National Institutes of Health Clinical Center (CC) | Conditions: Lung Cancer, Lymphoma | Phase 1 | Status: COMPLETED